AWAK Attracts Investment Billions
Singapore-based AWAK Technologies’ miniaturized sorbent platform for PD and HD regenerates dialysate to use up to 90% less fluid. This package was intriguing enough to attract an $11.2B investment from Accuron MedTech—improving its changes of reaching the market!
Read the full article » | Posted 06/12/2017
- Bring Home the Bacon Posted 02/15/2018
- A PD Solution to Protect Peritoneal Membranes Posted 01/11/2018
- The V-Wing Didn’t Make It; Perhaps the AV-Guardian Will? Posted 01/11/2018
- Print a Kidney Posted 01/11/2018
- Baxter Theranova: More Middle Molecules, Less Albumin Loss Posted 12/14/2017